InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by Brennan David R, Director. Officer active across 5 companies, notably ALEXION PHARMACEUTICALS, INC.. In total, 11 reports have been published. Total volume traded: €522k. The latest transaction was filed on 1 November 2021 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Declarations11 total
3,305 shares
Common Stock
SEC:0001609305-26-000004·
3,305 shares
Common Stock
SEC:0001609305-26-000004:0·
14,645 shares
Common Stock
SEC:0001140361-22-019182:0·
€260,88810,000 shares@ €26.08880.0007% mcap100.0% of flow
Common Stock
SEC:0001140361-21-036422·
Ideal exit: 29 Jul 2022 (T+270)
€260,88810,000 shares@ €26.08880.0007% mcap100.0% of flow
Common Stock
SEC:0001140361-21-036422:0·
Ideal exit: 29 Jul 2022 (T+270)
020,873 shares0
Common Stock, par value $.0001 per share
SEC:0000899866-21-000070·
020,873 shares0
Common Stock, par value $.0001 per share
SEC:0000899866-21-000070:0·
01,962 shares0
Common Stock, par value $.0001 per share
SEC:0000899866-21-000040·
01,962 shares0
Common Stock, par value $.0001 per share
SEC:0000899866-21-000040:0·
7,558 shares
Common Stock
SEC:0001140361-21-017417·
7,558 shares
Common Stock
SEC:0001140361-21-017417:0·
11 of 11 declarations
About Brennan David R
David R. Brennan is a Director at INSMED Inc and ALEXION PHARMACEUTICALS, INC. In these roles, he contributes to the strategic direction of the companies and oversees their operations. His expertise in the biopharmaceutical sector is valuable in guiding Insmid and Alexion's strategic decisions.
